I

IHH Healthcare Bhd
OTC:IHHHF

Watchlist Manager
IHH Healthcare Bhd
OTC:IHHHF
Watchlist
Price: 1.71 USD
Market Cap: $15.1B

P/E

37.1
Current
53%
More Expensive
vs 3-y average of 24.2

Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.

P/E
37.1
=
Market Cap
$77.5B
/
Net Income
2.1B

Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.

P/E
37.1
=
Market Cap
$77.5B
/
Net Income
2.1B

Valuation Scenarios

IHH Healthcare Bhd is trading above its 3-year average

If P/E returns to its 3-Year Average (24.2), the stock would be worth $1.12 (35% downside from current price).

Statistics
Positive Scenarios
0/4
Maximum Downside
-58%
Maximum Upside
No Upside Scenarios
Average Downside
33%
Scenario P/E Value Implied Price Upside/Downside
Current Multiple 37.1 $1.71
0%
3-Year Average 24.2 $1.12
-35%
5-Year Average 27.5 $1.27
-26%
Industry Average 32 $1.48
-14%
Country Average 15.5 $0.72
-58%

Forward P/E
Today’s price vs future net income

Today's Market Cap Net Income Forward P/E
$77.5B
/
Jan 2026
2.1B
=
37.1
Current
$77.5B
/
Dec 2026
2.3B
=
34.2
Forward
$77.5B
/
Dec 2027
2.6B
=
30
Forward
$77.5B
/
Dec 2028
3B
=
26.1
Forward

Forward P/E shows whether today’s P/E still looks high or low once future net income are taken into account.

Market Distribution

Lower than 86% of companies in Malaysia
Percentile
14th
Based on 500 companies
14th percentile
7.2
Low
0.1 — 10.9
Typical Range
10.9 — 23.6
High
23.6 —
Distribution Statistics
Malaysia
Min 0.1
30th Percentile 10.9
Median 15.5
70th Percentile 23.6
Max 227 361.7

IHH Healthcare Bhd
Glance View

In the vast landscape of global healthcare, IHH Healthcare Berhad stands as a towering presence, weaving a complex tapestry of patient care and medical excellence. Born in 2010 from a union of healthcare assets across Asia and beyond, IHH embarked on its journey to becoming one of the world's largest healthcare networks. Its reach spans more than ten countries, stretching from its strongholds in Malaysia and Singapore to burgeoning markets in Turkey, India, and Greater China. The company operates through renowned brands like Pantai, Parkway, and Acibadem, each serving as a hallmark of quality in their respective regions. By offering a comprehensive array of healthcare services, from primary to specialized care, and running top-tier hospitals and ambulatory facilities, IHH manages to touch millions of lives while ensuring an unyielding commitment to clinical excellence. The financial engine that drives IHH pivots on its robust model of vertically integrated healthcare services. Revenue pours in through a multi-faceted approach, chiefly grounded in patient fees for hospital admissions, surgical procedures, and outpatient services. IHH benefits from a strategic alignment with medical enterprises and insurance firms, ensuring a steady influx of patients while also securing long-term partnerships. The company’s emphasis on premium healthcare services, facilitated by cutting-edge technology and skilled practitioners, allows it to charge a premium price point. Moreover, IHH's investment in state-of-the-art technology and medical training bolsters its reputation as a leader in the field, further solidifying its market position. This strategic blend of geographic diversification and healthcare excellence crafts a resilient model that not only profits but also enhances the quality of life across continents.

IHHHF Intrinsic Value
1.37 USD
Overvaluation 20%
Intrinsic Value
Price $1.71
I
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett